Natasha Kaye’s Post

In an article spotlighting Cooley LLP's 2023 Life Sciences Group of the Year recognition, Law360 spoke with partners Marc Recht and Chad Shear, as they discussed how the firm's longstanding biotech industry leadership, collaborative workplace culture and breadth of practice play key roles in Cooley's accomplishments across the life sciences ecosystem. Subscribers can read more with the link below. #TeamCooley

In an article spotlighting Cooley LLP's 2023 Life Sciences Group of the Year recognition, Law360 spoke with partners Marc Recht and Chad Shear, as they discussed how the firm's longstanding biotech industry leadership, collaborative workplace culture and breadth of practice play key roles in Cooley's accomplishments across the life sciences ecosystem. Subscribers can read more with the link below. #TeamCooley

In an article spotlighting Cooley LLP's 2023 Life Sciences Group of the Year recognition, Law360 spoke with partners Marc Recht and Chad Shear, as they discussed how the firm's longstanding biotech industry leadership, collaborative workplace culture and breadth of practice play key roles in Cooley's accomplishments across the life sciences ecosystem. Subscribers can read more with the link below. #TeamCooley

In an article spotlighting Cooley LLP's 2023 Life Sciences Group of the Year recognition, Law360 spoke with partners Marc Recht and Chad Shear, as they discussed how the firm's longstanding biotech industry leadership, collaborative workplace culture and breadth of practice play key roles in Cooley's accomplishments across the life sciences ecosystem. Subscribers can read more with the link below. #TeamCooley

In an article spotlighting Cooley’s 2023 Life Sciences Group of the Year recognition, Law360 spoke with partners Marc Recht and Chad Shear, as they discussed how the firm's longstanding biotech industry leadership, collaborative workplace culture and breadth of practice play key roles in Cooley's accomplishments across the life sciences ecosystem. Subscribers can read more with the link below. Cooley's global life sciences practice spans corporate, litigation, regulatory and intellectual property capabilities, with almost 280 partners, associates, paralegals and other legal professionals attached to life sciences work of some kind across all 19 offices. Learn more here: https://bit.ly/49Kvv8f #lifesciences #leadership #biotech #TeamCooley

Excited to lead this dinner discussion. If we're all using the same list building DB/Tech, no advantage. Of recent, there has been a wave of startups that aggregate traditional and disparate private company data sources. Over dinner, we'll discuss how we use tech now, and how some of these new tools (Yes, some with AI!) might create an advantage. Dinner attendees encouraged to share their best practices (even if they're analog). https://lnkd.in/ebf-YCwC #dealsourcing #acgnewjersey #CDForumDinner

Experiencing slow enrollment in your study? Considering a hybrid approach? Beware of common misconceptions about the design and execution of DCTs and engage with experts with real-world experience. At UBC, we understand the importance of debunking DCT mythologies and authentically address key considerations necessary to execute a successful hybrid study design strategy. Learn how UBC can help https://hubs.li/Q02KtXtF0 #PatientsFirst #DCT #Pharma #RWE

The 2024 LMG Life Sciences Awards has named BELLUS Health’s US$2-billion sale to GSK as an Impact Deal of the Year (for the Americas). LMG Life Sciences nominates key legal players in the life sciences industry and recognizes their most outstanding work in this field. We are thankful for this recognition and to our clients for entrusting us with their most important matters. Congratulations to our lawyers who acted as counsel for BELLUS Health: Sebastien Roy, Steven Cutler, Amélie Doyon, Ryan Brun and Noah Abitbol (Corporate and Public M&A); Brian Bloom and Taj Kudhail (Tax); Charles Tingley and Dajena Pechersky (Competition, Antitrust and Foreign Investment); Hélène Bussières (Employment, Labour and Executive Compensation); and Louis-Martin O'Neill and Faiz Lalani (Dispute Resolution). Learn more about Davies’ work in Life Sciences: https://ow.ly/3Of050ThzsS #CanadianLaw #DaviesLaw #Awards #Law

The law firm ARQIS, with the team of Jörn-Christian Schulze (pictured), together with the law firm Franzosi Dal Negro Setti, with the lawyers Francesco Setti and Stefano Giberti, managed the transaction of the global dossier ownership and exclusive licence to the Proctosedyl® trademark in Italy from Bayer to Karo Healthcare. “This acquisition adds a reliable brand that addresses an often overlooked category with untapped potential. We are excited about the opportunity to improve access to reliable treatments for Italian consumers and add further scale and reach to our business in Italy,” says Matt Roberts, CC Rewarding expertise in life sciences and acquisitions. Read the full article >> https://lnkd.in/ddUimKQv #Legalcommunitygermany #legaladvisor #acquisition

Under the lead of Andreas Mayr and Florian Nikolai, DORDA advised Merz Group in the complex separation of its Aesthetics and Therapeutics divisions in Austria. 🩺💉 The transaction included the transfer of the Austrian Aesthetics division from the Austrian Merz Pharma Austria GmbH to a #ShelfCo by way of an asset deal. DORDA advised Merz Group on legal issues with a focus on life sciences and corporate law. The cooperation included the comprehensive support of the client throughout the entire transaction process. 🤝 Also advising on the transaction were: Francine Brogyanyi, Christoph Brogyányi, Florina Thenmayer, Katrin Repic, Stanislav Nekrasov, Isabel Maurer and Katja Ausweger #DORDA #Clarity #Transaction #MnA #AssetDeal